Friday, July 31, 2026

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

Pyongyang’s Nuclear Submarine Plans Face Serious Setbacks, Say Military Experts

North Korea's nuclear submarine ambitions face technical hurdles, even with Russian help, according to experts analyzing its capabilities.

Bitcoin Surges Back to 61,000 USD: What Does This Mean for Asian Investors?

Bitcoin's price rises above 61,000 USD as U.S. job growth slows, easing Fed rate hike fears and boosting investor confidence in risk assets.

Tag: CDMO strategies

Lotte Biologics Unveils Dual-Site Strategy: A Game Changer for Global CDMO in 2027

Lotte Biologics aims to lead in the evolving biotech landscape with dual sites in the U.S. and South Korea, enhancing global supply chains.

Top News

- Our Sponsors Ad -

Follow us